B-Type Natriuretic Peptides and Their Relation to Cardiovascular Structure and Function in a Population-Based Sample of Subjects Aged 70 Years

American Journal of Cardiology

Volumn 103, Issue 7, 2009, Pages 1032-1038

  Eggers, Kai M ^a   Lindahl, Bertil ^a   Venge, Per ^b   Lind, Lars ^b  

^a UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

AGED; AMINO TERMINAL SEQUENCE; ANATOMY; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CAROTID ARTERY; CAUCASIAN; CORRELATION ANALYSIS; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SWEDEN; SYSTOLIC DYSFUNCTION;

AGED; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; COMPLIANCE; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; IMMUNOASSAY; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; VASCULAR RESISTANCE; VASODILATION; VENTRICULAR FUNCTION, LEFT;

EID: 62849114796     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.12.014     Document Type: Article

References (18)

1. Chong A.Y., Blann A.D., Patel J., Freestone B., Hughes E., and Lip G.Y. Endothelial dysfunction and damage in congestive heart failure. Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation 110 (2004) 1794-1798
2. Abdullah S.M., Khera A., Das S.R., Stanek H.G., Canham R.M., Chung A.K., Morrow D.A., Drazner M.H., McGuire D.K., and de Lemos J.A. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study). Am J Cardiol 96 (2005) 1284-1289
3. Ninomiya Y., Hamasaki S., Ishida S., Kataoka T., Saihara K., Okui H., Orihara K., Fukudome T., Shinsato T., Ichiki T., et al. Elevated levels of brain natriuretic peptide as a predictor of impaired coronary endothelial function in patients with left ventricular remodelling. J Cardiol 48 (2006) 125-132
4. Lind L., Fors N., Hall J., Marttala K., and Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilatation in the elderly. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Arterioscler Thromb Vasc Biol 25 (2005) 2368-2375
5. Eggers K.M., Lind L., Ahlström H., Bjerner T., Ebeling Barbier C., Larsson A., Venge P., and Lindahl B. Prevalence and pathophysiologic mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 18 (2008) 2252-2258
6. Levey A.S., Greene T., Kusek J.W., Beck G.J., and MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A
7. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Working Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
8. Devereux R.B., Dahlöf B., Levy D., and Pfeffer M.A. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 78 (1996) 61-65
9. Lind L., Fors N., Hall J., Marttala K., and Stenborg A. A comparison of three different methods to determine arterial compliance in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. J Hypertens 24 (2006) 1075-1082
10. Vasan R.S., Benjamin E.J., Larson M.G., Leip E.P., Wang T.J., Wilson P.W., and Levy D. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham study. JAMA 288 (2002) 1252-1259
11. Abhayaratna W.P., Marwick T.H., Becker N.G., Jeffery I.M., McGill D.A., and Smith W.T. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide. Am Heart J 152 (2006) 941-948
12. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., Jacobsen S.J., Heublein D.M., and Burnett Jr. J.C. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. Determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 345-353
13. Wallace T.W., Abdullah S.M., Drazner M.H., Das S.R., Khera A., McGuire D.K., Wians F., Sabatine M.S., Morrow D.A., and de Lemos J.A. Prevalence and determinants of troponin T elevation in the general population. Circulation 113 (2006) 1958-1965
14. Jeremias A., and Gibson M. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142 (2005) 786-791
15. Madhani M., Scotland R.S., MacAllister R.J., and Hobs A.J. Vascular natriuretic peptide receptor-linked particulate guanylate cyclises are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139 (2003) 1289-1296
16. Vita J.A. Endothelial function and outcome. Heart 91 (2005) 1278-1279
17. Tateishi J., Masutani M., Ohyanagi M., and Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23 (2000) 776-780
18. Hammerer-Lercher A., Ludwig W., Falkensammer G., Müller S., Neubauer E., Puschendorf B., Pachinger O., and Mair J. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers. Clin Chem 50 (2004) 1174-1183